The most dangerous word in B2B sales isn't "no." It's "maybe". Specifically, the kind of "maybe" that lives in a pipeline full of deals that aren't moving, forecasts that don't mat...
If you're still measuring your cold email performance against benchmarks from 2022, you're not optimizing, you're guessing. And in 2026, guessing is expensive.
Most B2B companies don't have a lead generation problem. They have a conversation problem, and they're trying to solve it with the wrong people, the wrong process, or both.
If you sell into healthcare, manufacturing, finance, energy, SaaS, IT, logistics, cybersecurity, or industrial markets, normal lead generation advice is not enough.
The top healthcare lead generation companies in the USA in 2026 are Revnew, Salaria Sales Solutions, Callbox, Abstrakt Marketing Group, Martal Group, Vsynergize, Intelemark, SalesR...
You're not losing deals because your product is weak. You're losing them because your pipeline is full of the wrong people, and your team doesn't know it yet.
